Disease/Infection News

RSS

Advancing influenza vaccine development: Sino Biological launches antigens for the 2026-2027 Northern Hemisphere influenza vaccine strains

The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition.

From Sino Biological Inc. 4 Mar 2026

Chile verified as leprosy free after decades of public health efforts

The World Health Organization (WHO), together with the Pan American Health Organization (PAHO), congratulates Chile for becoming the first country in the Americas – and the second globally – to be officially verified as having eliminated leprosy disease.

4 Mar 2026

Why measles remains one of the most contagious viral diseases worldwide

This review synthesizes current evidence on measles virus biology, immune responses, complications, treatments, and prevention strategies. It highlights how measles can suppress immune memory, increasing susceptibility to other infections, and underscores vaccination as the most effective control measure.

4 Mar 2026

Nearly 70 weeks after infection, long COVID patients show no detectable inflammation in blood tests

A controlled Norwegian case-control study examined circulating biomarkers of inflammation and neuronal injury in people with long COVID about 69 weeks after infection. The researchers found no significant differences in systemic inflammatory or neuroinjury markers compared with recovered controls after statistical correction.

4 Mar 2026

Researchers identify TRIM13 protein as key driver of immune suppression in sepsis

Dendritic cells (DCs) are increasingly recognized as important contributors to sepsis-associated immune dysfunction.

4 Mar 2026

Study uncovers a biological cause for persistent taste loss after COVID-19

Some individuals have experienced a loss of taste long after a COVID-19 infection has subsided. Researchers from the Swedish University of Agricultural Sciences, Uppsala University and the University of Colorado have now shown that this may be due to a disruption in taste cells that would otherwise give rise to experiences of sweet, bitter or umami.

4 Mar 2026

Natural fungal supplement strengthens vaccine protection without increasing side effects

Researchers at University California San Diego School of Medicine have found that a natural fungal supplement taken at the time of COVID-19 vaccination reduced short-term vaccine side effects and helped antibodies - the body's natural immune defenders - last longer in people who had not previously been exposed to the virus.

4 Mar 2026

Gut microbiota-derived metabolite directly shapes immune responses in bacterial pneumonia

Sepsis and severe pneumonia are frequently accompanied by disruption of the gut microbiota, leading to immune dysfunction and increased susceptibility to secondary infections.

4 Mar 2026

New HIV-seq tool advances understanding of persistent viral reservoirs

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and transmission.

3 Mar 2026

Research suggests new therapeutic targets for broad-spectrum antiviral drugs

Coronaviruses not only use the machinery of the human cells they infect: they modify it to achieve optimal conditions to produce viral proteins and thus spread more quickly. This is the main conclusion of a study by Pompeu Fabra University published in Nature Communications.

3 Mar 2026

New method isolates true transcription factor targets in tuberculosis bacteria

Inside every cell, thousands of molecular signals collide, overlap, and compensate, obscuring the true drivers of gene expression.

2 Mar 2026

Can brain training prevent dementia? Long-term trial shows speed training with boosters makes a difference

A 20-year follow-up of older adults in the ACTIVE randomized trial linked to Medicare claims found that speed of processing cognitive training with booster sessions was associated with a significantly lower risk of diagnosed Alzheimer’s disease and related dementias. Memory and reasoning training did not show comparable long-term reductions in dementia risk.

2 Mar 2026

COVID-19 ARDS survivors face lasting disability and high late mortality, researchers report

In this single-center ambispective cohort of 283 Polish patients with COVID-19–related ARDS requiring invasive mechanical ventilation, cumulative mortality reached 44.5% at four years after ICU admission. Among survivors, substantial proportions reported persistent functional limitations, insomnia, fatigue, and reduced quality-adjusted life years.

2 Mar 2026

New research initiative aims to predict and prevent diseases before they start

What if doctors could tell you a disease was coming years before you felt a single symptom-and stop it in its tracks? That is the goal of a sweeping new research initiative launched by the Icahn School of Medicine at Mount Sinai in collaboration with the Uniformed Services University of the Health Sciences (USU) and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF).

2 Mar 2026

Machine learning predicts who will decline faster in Alzheimer’s disease using routine clinic data

Researchers developed and validated ElasticNet machine learning models that predict 12-month MMSE and BADL outcomes in Alzheimer’s disease and mild cognitive impairment using routinely collected clinical data. The cognitive model demonstrated external validation in ADNI, showing that individualized progression forecasting is feasible without biomarkers or neuroimaging.

1 Mar 2026

Acoziborole receives positive opinion for single-dose sleeping sickness treatment

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion to Acoziborole Winthrop (acoziborole) as a single-dose oral treatment for both early- and advanced-stage gambiense sleeping sickness in adults as well as in adolescents 12 years and older weighing at least 40 kilograms.

27 Feb 2026

Disease/Infection News

Advancing influenza vaccine development: Sino Biological launches antigens for the 2026-2027 Northern Hemisphere influenza vaccine strains

Chile verified as leprosy free after decades of public health efforts

Why measles remains one of the most contagious viral diseases worldwide

Nearly 70 weeks after infection, long COVID patients show no detectable inflammation in blood tests

Researchers identify TRIM13 protein as key driver of immune suppression in sepsis

Study uncovers a biological cause for persistent taste loss after COVID-19

Natural fungal supplement strengthens vaccine protection without increasing side effects

Gut microbiota-derived metabolite directly shapes immune responses in bacterial pneumonia

New HIV-seq tool advances understanding of persistent viral reservoirs

Research suggests new therapeutic targets for broad-spectrum antiviral drugs

New method isolates true transcription factor targets in tuberculosis bacteria

Can brain training prevent dementia? Long-term trial shows speed training with boosters makes a difference

COVID-19 ARDS survivors face lasting disability and high late mortality, researchers report

New research initiative aims to predict and prevent diseases before they start

Machine learning predicts who will decline faster in Alzheimer’s disease using routine clinic data

Acoziborole receives positive opinion for single-dose sleeping sickness treatment

New structural insights pave way for hantavirus vaccines

PEX38 protein offers new target against tropical trypanosome diseases

Polystyrene nanoplastics influence Salmonella survival and antibiotic resistance

WHO updates 2026-2027 flu vaccine composition amidst viral evolution

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News